Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
468 |
|
Actual shortage: | 52 (11%) | |
Anticipated shortage: | 19 (4%) | |
Avoided shortage: | 9 (2%) | |
Resolved: | 388 (83%) | |
Discontinuation Reports |
68 |
|
To be discontinued: | 7 (10%) | |
Discontinued: | 51 (75%) | |
Reversed: | 10 (15%) | |
Late reports |
52 (10%) |
|
Overdue reports |
12 (15%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
METOPROLOL | 100MG | TABLET | Resolved | 2020-03-26 | 2021-02-11 | 109414 |
METOPROLOL | 50MG | TABLET | Resolved | 2020-03-26 | 2021-02-11 | 109417 |
BISOPROLOL | 5MG | TABLET | Resolved | 2020-03-26 | 2020-03-27 | 109422 |
OXYCODONE/ACET | 325MG 5MG | TABLET | Resolved | 2020-03-26 | 2020-06-03 | 109425 |
CANDESARTAN | 32MG | TABLET | Resolved | 2020-03-26 | 2020-04-01 | 109439 |
CANDESARTAN/HCTZ | 12.5MG 16MG | TABLET | Resolved | 2020-03-26 | 2020-04-03 | 109442 |
TELMISARTAN | 40MG | TABLET | Resolved | 2020-03-26 | 2020-05-12 | 109445 |
CANDESARTAN | 8MG | TABLET | Resolved | 2020-05-11 | 2020-10-21 | 114758 |
GABAPENTIN | 800MG | TABLET | Resolved | 2020-05-11 | 2020-10-21 | 114766 |
GABAPENTIN | 600MG | TABLET | Resolved | 2020-05-11 | 2020-10-21 | 114770 |
MYCOPHENOLATE MOFETIL | 500MG | TABLET | Resolved | 2020-07-08 | 2020-12-11 | 119728 |
TELMISARTAN | 40MG | TABLET | Resolved | 2020-07-08 | 2020-10-21 | 119744 |
CITALOPRAM | 20MG | TABLET | Resolved | 2020-10-20 | 2020-10-30 | 126740 |
LISINOPRIL/HCTZ (TYPE Z) | 10MG 12.5MG | TABLET | Resolved | 2020-10-20 | 2020-11-19 | 126743 |
MEMANTINE | 10MG | TABLET | Resolved | 2020-10-20 | 2021-02-11 | 126746 |
FAMOTIDINE | 20MG | TABLET | Resolved | 2020-10-29 | 2024-03-02 | 127488 |
FAMOTIDINE | 40MG | TABLET | Resolved | 2020-10-29 | 2020-12-11 | 127491 |
TERAZOSIN | 2MG | TABLET | Resolved | 2021-03-10 | 2024-03-02 | 135430 |
TERAZOSIN | 5MG | TABLET | Resolved | 2021-03-10 | 2024-03-02 | 135433 |
TERAZOSIN | 1MG | TABLET | Resolved | 2021-03-10 | 2024-03-02 | 135436 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2389 |
DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
MORPHINE SR | 15MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-04-08 | 2020-06-13 | 111515 |
MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-04-08 | 111518 |
MORPHINE SR | 60MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-06-03 | 111521 |
BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151302 |
BUPROPION SR | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151307 |